ALGO BIOTECHNOLOGIES

Antonio Di Stefano is a full professor of technology, socioeconomics, and pharmaceutical legislation at the Department of Pharmacy of the University of Chieti-Pescara. Lisa Marinelli's research interest focuses on pharmaceutical technology, including the design, synthesis, and release of new drugs conceived for the treatment of neurodegenerative and microbial diseases. The growth strategy appears linked to partnerships and ecosystem development. It targets Lisa Marinelli's research interest is focused on pharmaceutical technology including the design, synthesis and delivery of novel drugs designed to treat neurodegenerative and microbial diseases. Stated strengths: declared technological differentiation on the product. The defensible advantage appears to rest on proprietary technology or know-how. Il settore della salute richiede attenzione a privacy, gestione dei dati sensibili e, quando rilevante, conformita clinica.